Dupixent now spans nine indications while Adbry and Ebglyss block IL-13 alone in atopic dermatitis. A clinician guide to indications, safety, interactions, and monitoring. Medscape Medical News
Dupixent now spans nine indications while Adbry and Ebglyss block IL-13 alone in atopic dermatitis. A clinician guide to indications, safety, interactions, and monitoring. Medscape Medical News